England pharmacies to prescribe medication for five more conditions from autumn

A £340 million deal in England will allow pharmacists to prescribe medication for five additional common conditions starting this autumn. The expansion is aimed at reducing pressure on GP surgeries and improving patient access to healthcare. The move represents a significant shift in how pharmacy services are delivered across England.

England is set to expand pharmacy prescribing powers under a new £340 million deal that will allow pharmacists to treat five additional common conditions without patients needing to first visit a GP. The changes are expected to come into force this autumn, marking a major step in the transformation of community pharmacy services.

The agreement is designed to ease the burden on family doctors and reduce waiting times for patients seeking treatment for routine ailments. By giving pharmacists greater prescribing authority, the National Health Service hopes to free up GP appointments for more complex cases while making healthcare more accessible on the high street.

The specific conditions covered by the new prescribing rights have not yet been fully detailed publicly, but they are described as common ailments for which patients currently often require a GP visit to obtain medication. The £340 million investment underlines the government's commitment to repositioning pharmacies as a frontline healthcare provider in England.